Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The 336 merged reexam decision
Reply New Message
Prev Message Back To Forum Threaded View Next Message

So what are you saying? The regulation says that the owner can file an ammendment or new claim(s) -

<in order to distinguish the invention as claimed from the prior art cited >

Are you in agreement? The ammendment must be for the purpost of distinguishing it from prior art? One would better wait for the rejection based on prior art before they submit anything. Right? Thanks Opty

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply